focus -WSS

focus

author：focus 2025-10-01 04:11:47 - browse：468

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： HHS leader on health, climate change and biopharma emissions

knowledge

WSS

ARCH Venture Partners is raising $3 billion for a life sciences fund

Commercial surrogacy can be ethical, despite pope’s claims

Biden administration opens offers in Medicare drug price negotiations

ARCH Venture Partners is raising $3 billion for a life sciences fund

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

hotspot

focus

hotspot

Peter Hotez and the public health issue of online harassment

Cognito secures funding to test medical device for Alzheimer's

Medicare proposal to cover medical devices draws a mixed reaction

FDA struggles to regulate food additives, sometimes for decades

Anesthesiologist group: stop taking Ozempic before surgery

STAT Summit: How a Chicago ER doctor tackles gun violence

Affirmative action in medical school literally saved lives

Time to name cancers by genetics, not organ of origin, expert says

Continuity nursing helped my family in our darkest PICU moments

Quicker fix for pulse oximeters urged during FDA public meeting

hotspot

Commercial surrogacy can be ethical, despite pope’s claims

Apple Vision Pro: A first look at health apps on the new VR headset

STAT Summit: How a Chicago ER doctor tackles gun violence

Impact of Dobbs ruling felt at reproductive medicine meeting

Cybersecurity threat forces Lurie Children's to take systems offline

Do digital therapeutics have a future in medicine?

knowledge

knowledge

hotspot

focus